Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-09-16
1999-10-05
Kemmerer, Elizabeth
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 8, 530399, 530397, 530350, 435 691, 435 694, 435 697, C07K 1400, C07K 1461, A61K 3816, A61K 3827
Patent
active
059624116
ABSTRACT:
There is provided a DNA (or RNA) polynucleotide sequences encoding naturally occurring splice variants of human growth hormone, hGHV-2(88) and hGHV-3(53) as well as analogs and derivatives thereof, which both lack nucleotide sequences normally present in the gene which codes for wild-type hGH. The growth hormone variants of the present invention are of human origin and are useful for diagnostic preventative and therapeutic purposes with respect to certain human diseases. The present invention is also related to a method for producing the human growth hormone variants by recombinant DNA techniques. A method of generating an antibody directed against and therefore inhibiting the activity of wild-type growth hormone is also provided.
REFERENCES:
patent: 3565987 (1971-02-01), Schuurs
patent: 4446235 (1984-05-01), Seeburg
patent: 4670393 (1987-06-01), Seeburg
patent: 4816439 (1989-03-01), Jorgensen
patent: 5597709 (1997-01-01), Rosen et al.
Nishikawa et al. Protein Engineering 3:49-53, 1989.
Schlesinger et al., Macromolecular Sequencing and Synthesis, Alan R. Liss, Inc., New York, pp. 127-149, 1988.
Bowie, et al., Science, 247:1306-1310 (1990).
Lewin, Ed., Genes II p. 681 (1985).
Estes, P.A., et al., J. Biol. Chem. 265:19863-19870 (1990).
Estes, P. A., et al., J. Biol. Chem. 267: 14902-14908 (1992).
Cooke, N. E., et al., J. Clin. Invest., 82: 270-275 (1988).
Estes, et al., ACTA Paediatr. Suppl. 399:42-47 (1994).
Roskam, W.G. et al., Nucleic Acid Res., 7:305-319 (1979).
Fiddes, J. C. et al., Biochemistry, 76:4294-4298 (1979).
Martial, J. A. et al., Science, 205:602-7 (1979).
Cooke, N. E., et al., J. Biol. Chem., 263: 9001-9006 (1988).
Ray, J., et al., J. Biol. Chem., 265:7939-7944 (1990).
Brinster, R. L. et al., Phil. Trans. R. Soc. Lond., 307:309-312 (1984).
Nickel, et al., Molecular Cell. Endocrin., 91:159-166 (1993).
Nickel, et al., Endocrinology, 126:971-976 (1990).
Denoto, et al., Nucleic Acids Research, 9:3719-3730 (1981).
Masuda, et al., Biochimica., 949:125-131 (1988).
Nishikawa, S., et al., Protein Engineering. 3:49-53 (1989).
Lecomte C. M., et al., Nucleic Acids Research, 15:6331-6348 (1987).
Uchida, E., et al., Bioch. & Biophisical Research Comm., 172:357-363 (1990) .
Adams Mark D.
Coleman Timothy A.
Gocayne Jeannine D.
Rosen Craig A.
Brookes A. Anders
Human Genome Sciences Inc.
Kemmerer Elizabeth
LandOfFree
Human growth hormone variants and methods of administering same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human growth hormone variants and methods of administering same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human growth hormone variants and methods of administering same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1171412